2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide

C20H21ClF3N3O5 — CID 142528037

IUPAC2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide
SMILESC=C(CCc1nnc(C2CC(OC(F)(F)F)C2)o1)NC(=O)C(CO)Oc1ccc(Cl)cc1
InChIInChI=1S/C20H21ClF3N3O5/c1-11(25-18(29)16(10-28)30-14-5-3-13(21)4-6-14)2-7-17-26-27-19(31-17)12-8-15(9-12)32-20(22,23)24/h3-6,12,15-16,28H,1-2,7-10H2,(H,25,29)
InChIKeyMVVAIKASCVVZLI-UHFFFAOYSA-N
MW475.85 g/mol
LogP3.51
Rot. Bonds10

About 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide

2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide (PubChem CID 142528037) has the molecular formula C20H21ClF3N3O5 and a molecular weight of 475.85 g/mol. Its IUPAC name is 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide.

Molecular Properties

Compound Name2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide
PubChem CID142528037
Molecular FormulaC20H21ClF3N3O5
Molecular Weight475.85 g/mol
Exact Mass475.11
IUPAC Name2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide
SMILESC=C(CCc1nnc(C2CC(OC(F)(F)F)C2)o1)NC(=O)C(CO)Oc1ccc(Cl)cc1
InChIInChI=1S/C20H21ClF3N3O5/c1-11(25-18(29)16(10-28)30-14-5-3-13(21)4-6-14)2-7-17-26-27-19(31-17)12-8-15(9-12)32-20(22,23)24/h3-6,12,15-16,28H,1-2,7-10H2,(H,25,29)
InChIKeyMVVAIKASCVVZLI-UHFFFAOYSA-N
XLogP3.51
TPSA106.71 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500475.85
LogP ≤ 53.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide?
The IUPAC name of 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide (CID 142528037) is 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide.
What is the SMILES notation for 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide?
The canonical SMILES for 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide is C=C(CCc1nnc(C2CC(OC(F)(F)F)C2)o1)NC(=O)C(CO)Oc1ccc(Cl)cc1.
What is the InChIKey of 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide?
The InChIKey is MVVAIKASCVVZLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H21ClF3N3O5/c1-11(25-18(29)16(10-28)30-14-5-3-13(21)4-6-14)2-7-17-26-27-19(31-17)12-8-15(9-12)32-20(22,23)24/h3-6,12,15-16,28H,1-2,7-10H2,(H,25,29).
What are the key properties of 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide?
2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide has a molecular weight of 475.85 g/mol, XLogP of 3.51, 10 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-chlorophenoxy)-3-hydroxy-N-[4-[5-[3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]but-1-en-2-yl]propanamide is sourced from PubChem (CID 142528037), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).